Menstrual Health in Children, Adolescents, and Young Adults with Cardiac Disease: An Underrecognized Component of Heart Failure, Mechanical Circulatory Support, and Transplant Care

J Heart Lung Transplant. 2026 Oct 18:S1053-2498(26)02145-5. doi: 10.1016/j.healun.2026.10.011. Online ahead of print.ABSTRACTBACKGROUND: Menstrual abnormalities, including heavy menstrual bleeding, amenorrhea, and dysmenorrhea, are frequently encountered among children, adolescents, and young adults

H HaEun Jazmin Kim

Feature selection and dimensionality reduction in multi-omics

Genome. 2026 Oct 18. doi: 10.1139/gen-2026-0094. Online ahead of print.ABSTRACTHigh-throughput multi-omics technologies generate high-dimensional, heterogeneous and noisy datasets, making robust biomarker discovery and disease modelling challenging. This review critically examines dimensionality red

S Sweta Rai

Popliteal artery entrapment syndrome. Current concepts, dilemmas, and challenges

Br Med Bull. 2026 Oct 5;160(1):ldag034. doi: 10.1093/bmb/ldag034.ABSTRACTINTRODUCTION: Popliteal artery entrapment syndrome (PAES) results from extrinsic compression of the popliteal artery as it passes through the popliteal fossa due to congenital musculotendinous anomalies or acquired muscle hyper

L Laura Calsina-Juscafresa

Acinar-Derived Organoids Reveal Stage-Specific Control of Acinar Plasticity

Adv Sci (Weinh). 2026 Oct 18:e78350. doi: 10.1002/advs.78350. Online ahead of print.ABSTRACTAdult pancreatic acinar cells undergo ordered metaplastic conversion during injury and tumor initiation. Whether individual cells retain redifferentiation capacity after metaplastic expansion, and what signal

Y Yongfei Hou

β3-Adrenergic Receptor Agonism Reduces Right Ventricular Systolic Pressure in a Preclinical Model of Heart Failure With Preserved Ejection Fraction-Associated Pulmonary Hypertension

J Cardiovasc Pharmacol Ther. 2026 Jan-Dec;31:10742484261495417. doi: 10.1177/10742484261495417. Epub 2026 Oct 18.ABSTRACTPurposePulmonary hypertension (PH) commonly complicates heart failure with preserved ejection fraction (HFpEF), driving morbidity and mortality, yet no therapies exist for HFpEF-P

C Christelle Lteif